University of Washington high-dose cyclophosphamide, mitoxantrone, and etoposide experience in metastatic breast cancer: unexpected cardiac toxicity
- PMID: 11559728
- DOI: 10.1200/JCO.2001.19.18.3903
University of Washington high-dose cyclophosphamide, mitoxantrone, and etoposide experience in metastatic breast cancer: unexpected cardiac toxicity
Comment on
-
High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.J Clin Oncol. 1995 Oct;13(10):2483-9. doi: 10.1200/JCO.1995.13.10.2483. J Clin Oncol. 1995. Retraction in: J Clin Oncol. 2001 Jun 1;19(11):2973. doi: 10.1200/JCO.2001.19.11.2973. PMID: 7595697 Retracted. Clinical Trial.
-
An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications.J Clin Oncol. 2001 Jun 1;19(11):2771-7. doi: 10.1200/JCO.2001.19.11.2771. J Clin Oncol. 2001. PMID: 11387347 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
